Heart Failure Rescued by Pharmacological Inhibition of Type 5 Adenylyl Cyclase

被引：0
|
作者：
Iwatsubo, Kosaku [1 ]
Baljinnyam, Erdene [1 ]
Lai, Lo [1 ]
Hong, Chull [1 ]
Gao, Shumin [1 ]
Yan, Lin [1 ]
Vatner, Dorothy [1 ]
Sadoshima, Junichi [1 ]
Vatner, Stephen [1 ]
Ishikawa, Yoshihiro [1 ]
机构：
[1] UMDNJ NJMS, Newark, NJ USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Heart failure; Drugs; Myocardial infarction; Beta-blocker; Apoptosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11285
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adenylyl Cyclase Type 5 Disruption Prolongs Longevity and Protects the Heart Against Stress
    Vatner, Stephen F.
    Yan, Lin
    Ishikawa, Yoshihiro
    Vatner, Dorothy E.
    Sadoshima, Junichi
    CIRCULATION JOURNAL, 2009, 73 (02) : 195 - 200
  • [22] Novel pharmacological insights for adenylyl cyclase 5, a gatekeeper of GPCR signaling
    Siehler, Sandra
    Yamamoto, Rina
    Bergsdorf, Christian
    Leder, Lukas
    Reinhardt, Juergen
    Freuler, Felix
    Scheel, Guenther
    FASEB JOURNAL, 2010, 24
  • [23] Mechanism of Giα-mediated inhibition of type V adenylyl cyclase
    Chen, J
    Tesmer, JJG
    Sprang, SR
    Gilman, AG
    Dessauer, CW
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 285A - 285A
  • [24] Type 5 phosphodiesterase inhibition in heart failure
    Goldsmith, Steven R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (22) : 2145 - 2147
  • [25] Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration
    Iwatsubo, K
    Minamisawa, S
    Tsunematsu, T
    Nakagome, M
    Toya, Y
    Tomlinson, JE
    Umemura, S
    Scarborough, RM
    Levy, DE
    Ishikawa, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (39) : 40938 - 40945
  • [26] Allosteric Inhibition of Adenylyl Cyclase Type 5 by G-Protein: A Molecular Dynamics Study
    Frezza, Elisa
    Amans, Tina-Meryl
    Martin, Juliette
    BIOMOLECULES, 2020, 10 (09) : 1 - 17
  • [27] Decreased type VI adenylyl cyclase mRNA concentration and Mg2+-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn2+-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure
    Espinasse, I
    Iourgenko, V
    Richer, C
    Heimburger, M
    Defer, N
    Bourin, MC
    Samson, F
    Pussard, E
    Giudicelli, JF
    Michel, JB
    Hanoune, J
    Mercadier, JJ
    CARDIOVASCULAR RESEARCH, 1999, 42 (01) : 87 - 98
  • [28] Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats
    Jörg H. Bräunig
    Barbara Albrecht-Küpper
    Roland Seifert
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2014, 387 : 389 - 398
  • [29] Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats
    Braeunig, Jorg H.
    Albrecht-Kuepper, Barbara
    Seifert, Roland
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 (04) : 389 - 398
  • [30] PHARMACOLOGICAL INHIBITION OF ADENYLYL CYCLASE TYPE 5: A NOVEL THERAPEUTIC MODALITY TO REDUCE INFARCT SIZE EVEN WHEN DELIVERED AFTER CORONARY ARTERY REPERFUSION
    Zhang, Jie
    Levy, Daniel
    Richardson, Thomas
    Meenan, Christopher
    Yoon, Seonghun
    Vatner, Dorothy E.
    Vatner, Stephen F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 9 - 9
12345